Cell Freezing Media Market | USD 421.19 Million by 2034
The cell freezing media market size was exhibited at USD 167.95 million in 2024 and is projected to hit around USD 421.19 million by 2034, growing at a CAGR of 9.63% during the forecast period 2025 to 2034.
The U.S. cell freezing media market size reached USD 49.13 million in 2024 and is anticipated to be worth around USD 123.2 million by 2034, poised to grow at a CAGR of 8.71% from 2025 to 2034.
North America dominated the cell freezing media market with a share of 38.12% in 2024. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, presence of key players and established supply channels. Additionally, the prevalence of diseases and growing geriatric population has led to the race of developing advanced and efficacious therapies via biopharmaceutical industry. This has driven the demand for cell freezing media and is expected to continue revenue generation in the years to come.
Asia Pacific is expected to witness the fastest growth with a CAGR of 11.6% during 2025-2034. The Asia Pacific is a region with a supportive government, driven on low labor and operating cost and is a major hub for biologics manufacturing especially monoclonal antibodies (MAbs). The development of MAbs usually employs extensive use of mammalian cell cultures which are continuously processed and require cryopreservation.
| Report Coverage | Details |
| Market Size in 2025 | USD 184.13 Million |
| Market Size by 2034 | USD 421.19 Million |
| Growth Rate From 2025 to 2034 | CAGR of 9.63% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Product, Application, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Thermo Fisher Scientific, Inc.; Merck KgaA; Sartorius AG; BioLife Solutions, Inc.; Bio-Techne, HiMedia Laboratories; PromoCell GmbH; Capricorn Scientific; Cell Applications, Inc.; STEMCELL Technologies.; AMSBIO; Cell Systems; BPS Bioscience, Inc. |
The DMSO (dimethyl sulfoxide) segment accounted for the largest market share of 51.46% in 2024 and is even expected to witness the fastest growth during 2025-2034. This is due to the established gold standard from years of using DMSO in traditional cryopreservation for suspending the metabolic activities of cells. DMSO is the central player in cryobiology due its aprotic and solvation properties. It inhibits the ice crystal formation both intracellularly and extracellularly at sub-zero temperatures during slow freezing and thus, DMSO has observed widespread adoption as a cryoprotectant due to these antifreeze properties.
Moreover, it even provides protection from biological injuries during the process of cryopreservation. Consequently, multiple market competitors are therefore offering a range of DMSO based cell freezing media among other cell freezing media products. Various applications of DMSO based cell freezing media has also contributed to its largest market share. For example, Merck KGaA via its Sigma Aldrich brand offers multiple DMSO based cryopreservation media which are suitable to use for mammalian cancer cells lines and other cells lines.
Cryoprotective agents like glycerol are also used for cells freezing purpose. Key players are also aligning their cell freezing media products as per the market requirement of various concentrations of CPAs. This allows them to be research inclusive and increase the customer base to bolster the revenue generation. For instance, in March 2021, Thermo Fisher Scientific, Inc. launched a ‘Gibco Human Plasma-like Medium’ that has a metabolic profile similar to that of human plasma. This development has resulted in enhancing the company’s presence in cell culture media space.
The stem cell lines segment held the largest market share of 57.32% in 2024. The growing demand of biopharmaceuticals because of effective treatments like cell and gene therapy and upswing of innovation that resulted in a surge in approvals are the key contributing factors for the segment growth. It is estimated that the U.S. FDA would be approving around 10 to 20 products of cell and gene therapy each year by 2025 due to the current clinical success rates and the product pipeline. This has led the market players to ensure a successful supply network of all consumables considering the hike in demand in upcoming years. As a result, employing cell freezing media for continuous processing of these therapy products will also result in the fastest market penetration within the projected period.
The increasing prevalence of life-threatening diseases and the search for advanced therapies have resulted in intensive research in other areas such as cancer. Cell freezing media has also observed a significant market penetration for cancer cell lines and will grow steadily in the forthcoming years due to continued research activities for better healthcare.
The pharmaceutical and biotechnological companies segment captured the largest market share of 43.0% in 2024. The continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies has been attributed to the segment growth. The optimum protection and preservation by the cell preservation medium along with the cost effectiveness relative to traditional freezing technique has driven its adoption. The unceasing use of these consumables during research stage, clinical and even commercial stages is anticipated to contribute to market growth.
The research and academic institutes segment is expected to be fastest growing segment with a CAGR of 9.9% during 2023 - 2030. This rapid growth can be attributed to the increase in research and development activities in the forecast period. The COVID-19 pandemic has created awareness among the industry professionals along with the need of continuous research and development of existing technologies. The expected growth is also due to huge investment in terms of partnerships and collaboration with research institutes. For instance, NIBRT (National Institute of Bioprocessing Research and Training) announced in May 2024, a collaboration with Kerry Group and ValitaCell to enhance the understanding and validation of cell culture media products for the Kerry Group. ValitaCell will be providing its Chemstress platform for mimicking the biological environment in microscale. This project received funding from Enterprise Ireland to support innovation.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the cell freezing media market
By Product
By Application
By End-use
By Regional
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for cell-based therapies and regenerative medicine
3.2.1.2. Increasing R&D spending by biopharmaceutical and biotechnology companies
3.2.1.3. Advancements in cryopreservation techniques and biopreservation technologies
3.2.1.4. Increasing prevalence of chronic diseases and genetic disorders
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with cryopreservation and cell freezing media
3.2.2.2. Stringent regulatory requirements for cell-based products and cryopreservation systems
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cell Freezing Media Market: Product Movement Analysis
4.2. DMSO
4.2.1. DMSO Market, 2018 - 2030 (USD Million)
4.2.2. DMSO With Serum
4.2.2.1. DMSO With Serum Market, 2018 - 2030 (USD Million)
4.2.3. DMSO Without Serum
4.2.3.1. DMSO With Serum Market, 2018 - 2030 (USD Million)
4.3. Glycerol
4.3.1. Glycerol Market, 2018 - 2030 (USD Million)
4.3.2. Glycerol With Serum
4.3.2.1. Glycerol With Serum Market, 2018 - 2030 (USD Million)
4.3.3. Glycerol Without Serum
4.3.3.1. Glycerol With Serum Market, 2018 - 2030 (USD Million)
4.4. Others
4.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Cell Freezing Media Market: Application Movement Analysis
5.2. Stem Cell Lines
5.2.1. Stem Cell Lines Market, 2018 - 2030 (USD Million)
5.3. Cancer Cell Lines
5.3.1. Cancer Cell Lines Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Cell Freezing Media Market: End-Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Academic and Research Institutes
6.3.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Cell Freezing Media Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. U.S. Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Canada Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. UK Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Germany Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. France Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Italy Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Spain Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Denmark Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Sweden Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Norway Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. China Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. India Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. South Korea Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Brazil Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Mexico Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Argentina Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. South Africa Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Saudi Arabia Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. UAE Cell Freezing Media Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Kuwait Cell Freezing Media Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Sartorius AG
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Bio-Life Solutions, Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Techne
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. HiMedia Laboratories
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. PromoCell GmbH
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Capricorn Scientific
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Cell Applications, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. AMSBIO
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers